Terms: = Colorectal cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Clinical Outcome
4 results:
1. ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of clinical outcome in Patients with Gastric Carcinoma.
Wang T; Zhong H; Qin Y; Wei W; Li Z; Huang M; Luo X
Biomed Res Int; 2020; 2020():3575038. PubMed ID: 32685472
[TBL] [Abstract] [Full Text] [Related]
2. Tumour-infiltrating CD8
Glaire MA; Domingo E; Sveen A; Bruun J; Nesbakken A; Nicholson G; Novelli M; Lawson K; Oukrif D; Kildal W; Danielsen HE; Kerr R; Kerr D; Tomlinson I; Lothe RA; Church DN
Br J Cancer; 2019 Sep; 121(6):474-482. PubMed ID: 31388185
[TBL] [Abstract] [Full Text] [Related]
3. [Association of microvessel density and blood vessel invasion with the prognosis in rectal carcinoma at stages I to II].
Zhou YJ; Ye Q; Lu HS; Yang YH; Guan GX; Huang CM; Wang C; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jul; 13(7):516-9. PubMed ID: 20658366
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors and clinical outcome for anastomotic leakage after total mesorectal excision for rectal cancer.
Lee WS; Yun SH; Roh YN; Yun HR; Lee WY; Cho YB; Chun HK
World J Surg; 2008 Jun; 32(6):1124-9. PubMed ID: 18259805
[TBL] [Abstract] [Full Text] [Related]